Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Eighty four male Buffalo rats bearing transplantable Morris 5123
hepatoma
were used for the experiment. Half of the animals were given into the tumor BCG vaccine (final dose 2.2 X 10(6) living mycobacteria), the other 42 rats after BCG underwent surgical removal of the hind leg together with the tumor. Though the immunotherapy reduced the size of
lung metastases
of the tumor it did not, however diminish the survival rate of the animals. Multiple BCG doses associated with the surgical procedure prevented dissemination of the tumor cells and prolonged the survival of rats up to the 100th day of the follow-up.
...
PMID:The effect of repeated BCG vaccine administration associated with surgery upon the growth of lung metastases in rats with transplantable Morris 5123 hepatoma. 725 34
Primary
hepatocellular carcinoma
is a very rare disease, especially in association with a pregnancy. We report on a 22-year-old primigravida, who underwent Caesarean section in the 29th week of pregnancy in conjunction with tumour-reductive surgery for
hepatocellular carcinoma
. The further course of the disease was characterised by an early recurrence and
lung metastases
. Under palliative chemotherapy with 5-fluorouracil, the patient has been in a state of stable disease for several months. Typical risk factors for the
hepatocellular carcinoma
do not exist in the patient. Alternative explanations for the aetiology of the disease are discussed.
...
PMID:[Hepatocellular carcinoma in pregnancy]. 751 73
We report here a case of
hepatocellular carcinoma
(
HCC
) with multiple
lung metastases
, which were disappeared by treatment of OK-432. The patient was a 65-year-old man and was diagnosed in 1986 with a small (17 x 11 mm)
HCC
in the anterior-superior segment of the liver. A part of the right hepatic lobe including the tumor was surgically removed, and transarterial injections of adriamycin (10 mg/week) and subcutaneous injections of OK-432 (10 KE/week) were given. Two and a half years later, recurrence of
HCC
in the liver and its invasion to vena cava inferior (IVC) were found. OK-432 administration was then stopped and percutaneous ethanol injection therapy (PEIT) was performed 10 times. Six months later, the PEIT was effective and the liver tumor with IVC invasion diminished. However, multiple
lung metastases
were visible on roentgenograms of the chest, and serum alphafetoprotein (AFP) concentration increased to 50,000 ng/ml. The OK-432 treatment resumed. After 6 months of OK-432 treatment, the multiple
lung metastases
were disappeared and the serum AFP level decreased to 100 ng/ml. At present, the patient is surviving without any sign of recurrence in either the liver or the lung. The clinical course of this case suggests that OK-432 might have effectively treated
lung metastases
of
HCC
, although the exact mechanisms are at present unclear.
...
PMID:Disappearance of pulmonary metastases by OK-432 treatment in a case of hepatocellular carcinoma. 769 5
The in vitro expression level of interleukin-8 (IL-8) correlates with the metastatic potential of human melanoma cells. The purpose of this study was to determine whether the expression level of IL-8 in human melanoma cells is influenced by the organ microenvironment. A375P cells, a low metastatic human melanoma, and A375SM cells, a highly metastatic variant, were injected into the subcutis (s.c.), spleen (to produce liver metastases), and lateral tail vein (to produce
lung metastases
) of athymic nude mice. Northern blot and immunohistochemical analyses determined that s.c. tumors, lung lesions, and liver lesions expressed high, intermediate, and low IL-8, mRNA, and protein, respectively. This differential regulation of IL-8 was not due to the size or density of the lesions or to selection of subpopulations of cells. We based this conclusion on the results of three experiments: (a) melanoma cell lines established in culture from in vivo-growing tumors exhibited similar levels of IL-8 mRNA transcripts; (b) in a crossover experiment, the level of IL-8 mRNA was always high in A375 tumors reestablished in the skin and low in the tumors reestablished in the liver, regardless of whether the melanoma cells had been first harvested from s.c. or liver tumors; and (c) A375 melanoma cells cocultured with human keratinocytes produced high levels of IL-8 protein, whereas A375 cells cocultured with highly differentiated human
hepatoma
cells produced decreased levels. When A375P cells were then incubated with cytokines associated with keratinocytes (IL-1 and interferon beta) or hepatocytes (transforming growth factor alpha or beta), IL-1 enhanced the production of IL-8 protein, whereas TGF-beta decreased its production. These data show that IL-8 expression in melanoma cells is modulated by local host factors.
...
PMID:Regulation of interleukin-8 expression in human melanoma cells by the organ environment. 775 1
The heterocyclic aromatic amine 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) was evaluated for carcinogenic effects in macaques, primarily cynomolgus monkeys. IQ was administered by gavage five times a week at doses of 10 or 20 mg/kg. IQ induced
hepatocellular carcinoma
in 55% of the animals at the low dose and in 95% of the animals at 20 mg/kg. The average latent period at the high dose level was 43 months and that at the low dose was 60 months. Generally, the tumor nodules exhibited a well- to moderately well-differentiated
hepatocellular carcinoma
, and a trabecular pattern was most frequently seen.
Pulmonary metastases
were also found in several of the monkeys. Thus, IQ is a potent carcinogen in nonhuman primates and is a potential carcinogen for humans.
...
PMID:Induction of hepatocellular carcinoma in nonhuman primates by the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline. 803 33
A 65-year-old male with
hepatocellular carcinoma
was admitted to our hospital. Hepatic angiography showed a hypervascular tumor 8 cm in diameter in the right lobe of the liver with tumor emboli in the inferior vena cava and right atrium. Then, two chemoembolization treatments using gelform and cisplatin suspended in Lipiodol were performed. Although the size of the main tumor in the liver and tumor emboli was reduced, 6 months after the initial chemoembolization the serum levels of alfa-fetoprotein (AFP) and plasma des-gamma-carboxy prothrombin (DCP) rose to 14,000 ng/ml and 6.4 AU/ml, respectively, and multiple
lung metastases
were detected by CT scan. Then, 200 mg/day of UFT was administered orally. Four months after the administration, the levels of AFP and DCP markedly decreased to 95 ng/ml and 0.0 AU/ml, respectively, and the
lung metastases
and tumor emboli disappeared. Moreover, there were no side-effects including liver dysfunction.
...
PMID:[A case of hepatocellular carcinoma whose lung metastases and tumor emboli in the inferior vena cava disappeared by oral administration of UFT]. 806 Jan 44
Recombinant human interleukin 2 purified from Escherichia coli has a limited solubility at neutral pH and a short circulatory half-life. This recombinant interleukin 2 was chemically modified by an active ester of polyethylene glycol. The modified interleukin 2 presented in this paper showed an increased antitumor potency in murine
hepatoma
model, which included prolonging the survival of tumor-bearing mice (from 16.0 +/- 1.8 d to 20.2 +/- 0.9 d, P < 0.01), reducing the
lung metastases
of
hepatoma
(from 14.0 +/- 0.7 nodules to 7.5 +/- 1.8 nodules, P < 0.01) and inhibiting the subcutaneous tumor growth (P < 0.01). The results demonstrate that the polyethylene glycol modified interleukin 2 has a higher antitumor activity than unmodified interleukin 2 in vivo and is a potential immunological agent in the adoptive immunotherapy of
hepatoma
.
...
PMID:[In vivo antitumor activities of polyethylene glycol modified recombinant interleukin 2 (PEG-rIL-2) against murine hepatoma]. 817 61
A 62-year-old male patient was admitted for spontaneous rupture of
hepatocellular carcinoma
. He also had multiple
lung metastases
and liver dysfunction. So neither operation nor trans-arterial embolization could be performed. He had been administered UFT (400 mg/day) orally every day. After 5 months of daily administration, there was complete disappearance of multiple lung metastasis and reduction of the primary tumor. This case suggests that UFT is effective for some advanced
hepatocellular carcinoma
with extrahepatic metastasis.
...
PMID:[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis]. 867 24
We report clinical characteristics and CT and MRI in 16 patients with brain metastases due to
hepatocellular carcinoma
(
HCC
). Eight of these 16 patients presented with apoplexy-like symptoms (50%).
Pulmonary metastases
were found in 13 cases (81.3%). The mean survival from the appearance of cerebral metastases to death was 6.2 weeks, which is one of the shortest survival terms in metastatic brain tumours. Haemorrhagic brain metastases were observed in 14 patients (87.5%) with a tendency for the frequency of bleeding to increase in proportion to the size of the tumour. On both contrast-enhanced CT and MRI, metastatic brain tumours enhanced strongly, suggesting that brain metastases, like
HCC
, are also hypervascular. MRI is useful in evaluating brain metastases from
HCC
, especially in order to differentiate tumour from haemorrhage. Our results demonstrated a poor prognosis and bleeding tendency of brain metastases due to
HCC
and showed the usefulness of CT and MRI in achieving a correct diagnosis.
...
PMID:Intracranial metastases of hepatocellular carcinoma: CT and MRI. 881 76
This study describes histopathological findings in 26 nonhuman primates (cynomolgus and rhesus monkeys) with liver tumors after dosing with IQ for time periods of 27 to 72 months. In most of the cases 2-5 well-defined tumor nodules were present in the liver at the time of autopsy. In 5 cases there were numerous nodules occupying most of the liver. Intrahepatic vascular invasion was observed in 14 cases, and
lung metastases
in 6 cases. The histology of 72 nodules from 21 cases with well-defined tumors and the 5 cases with massive involvement was studied. The majority of the tumors represented well to moderately well-differentiated
hepatocellular carcinoma
(
HCC
). Trabecular pattern was most common, followed by solid and pseudoglandular patterns. Five nodules displayed poorly differentiated pleomorphic variant of
HCC
with large, often multinucleated, tumor cells. Spindle cell and clear cell variants of
HCC
were seen in one nodule each. Two nodules were classified as cholangiocarcinomas. Immunostaining for cytokeratins 7 and 19 did not prove to be reliable markers for tumors of bile duct origin, since they were also expressed in some of the poorly differentiated
HCC
. The most common microscopic finding of the noncancerous portions of the liver were clear cell foci, composed of large, glycogen rich hepatocytes with small eccentric nuclei. Other lesions commonly found were dysplastic hepatocyte foci around the central veins and proliferating bile ductular-like (oval) cells along the portal areas and portal tracts.
...
PMID:Histopathology of IQ-induced hepatocarcinogenesis in nonhuman primates. 884 19
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>